scispace - formally typeset
H

Hyeon-Min Cho

Researcher at Catholic University of Korea

Publications -  68
Citations -  906

Hyeon-Min Cho is an academic researcher from Catholic University of Korea. The author has contributed to research in topics: Colorectal cancer & Laparoscopic surgery. The author has an hindex of 15, co-authored 58 publications receiving 747 citations.

Papers
More filters
Journal ArticleDOI

Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model

TL;DR: Results provided evidence that electroporation of CIR RNA to human PBLs could be used for rapid generation and high number of therapeutic antigen-specific T cells for adoptive immunotherapy.
Journal ArticleDOI

Single-port transumbilical laparoscopic appendectomy: 43 consecutive cases.

TL;DR: Single-port appendectomy may require a longer operative time than laparoscopic appendectomy, but it is a feasible technique with good cosmetic results and could be one of the alternative methods for treating acute appendicitis.
Journal ArticleDOI

Multidimensional Analysis of the Learning Curve for Laparoscopic Rectal Cancer Surgery

TL;DR: Multidimensional analysis considering various surgical outcomes is necessary to evaluate the learning curve for laparoscopic rectal cancer surgery, and the effective surgical learning curve was approximately 60-80 procedures in this series.
Journal ArticleDOI

Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer

TL;DR: GLUT1 expression is a predictive and prognostic factor for pathologic complete response and recurrence in rectal cancer patients treated with 5-flurouracil and leucovorin neo-adjuvant chemoradiotherapy.
Journal ArticleDOI

Overview of Radiation Therapy for Treating Rectal Cancer

TL;DR: Long-course radiotherapy appears to provide effective local control and the same overall survival as more long-course chemoradiotherapy schedules and, therefore, may be an appropriate choice in some situations and Capecitabine is an acceptable alternative to infusion fluorouracil in those patients who are able to manage the responsibilities inherent in self-administered, oral chemotherapy.